Montelukast for Acute Bronchiolitis and Postbronchiolitis Viral Induced Wheezing

Montelukast for Acute Bronchiolitis and Postbronchiolitis Viral Induced Wheezing in Infants 3 to 12 Months of Age in Bandar Abbas Children' Hospital

The aim of the current study is to evaluate the effect of Montelukast in treatment of acute bronchiolitis and postbronchiolitis viral induced wheezing of infants 3 to 12 months of age in Bandar Abbas Children' hospital.

All the patients will be evaluated at the baseline, during hospitalization (daily) and at 2 months and 6 months after starting the intervention.

Inclusion Criteria:

• infant in 3-12 months of age with first episode of wheezing or bronchiolitis
• written informed consent by parents

Exclusion Criteria:

• Previous wheezing episode or confirmed asthma or bronchiolitis
• recent bronchodilator use
• immune deficient
• immunosuppressive drug use
• croup or pneumonia diagnosis
• loss of follow up